Última actualização :
08/05/2024
Curarizante   Suxamethonium chloride  
Injetável
Estabilidade em soluções simples Estabilidade em misturas Factores que afectam a sua estabilidade Compatibilidade Método de administração Bibliografía Pdf
   Estrutura química  

Nomes comerciais nos diversos países   Nomes comerciais nos diversos países     

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Actirelax Argentina
Anectine Emirados Árabes Unidos, Espanha, Estados Unidos de América, Gran-bretanha, Irlanda, México
Celocurin Suècia
Celocurine Bélgica, França
Chlorsucillin Polonia
Cholsuxinyl Egipto
Cloruro de succinilcolina Argentina
Cloruro de suxametonio Peru
Curacit Noruega
Distensil Peru
Entubate Índia
Ethicoline Malásia
Fosfitone Argentina, Venezuela
Lycitrope Grècia
Lysthenon Alemanha, Arábia Saudita, Austria, Emirados Árabes Unidos, Romènia, Suicia
Midarine Arábia Saudita, Itália, Suicia
Mioflex Espanha, Portugal
Miokolin Irã
Myoplegine Bélgica, Luxemburgo
Myotenlis Itália
Pantolax Alemanha
Quelicin Colômbia
Succi Argentina
Succinilcholina Argentina
Succinilcholina cloruro Peru
Succinolin Suicia
Succinyl Luxemburgo
Succinylcholine Alemanha, Canadá, Irã
Succyl Irã
Sukolin Finlandia
Suxamethonium Australia, Gran-bretanha, Irã, Irlanda, Malásia, Nova Zelândia
Suxametonio cloruro Chilli, Peru
Suxim Peru
Uxicolin Colômbia, México
Bibliografía   Injetável   Bibliografía : Suxamethonium chloride  
Tipo Publicação
45 Jornal Schmutz CW, Mühlbach SF.
Stability of succinylcholine chloride injection.
Am J Hosp Pharm 1991 ; 48: 501-506.
300 Jornal Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319 Jornal Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
667 Jornal Pramar YV, Moniz D, Hobbs D.
Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes.
J Clin Pharm Ther 1994 ; 19: 195-198.
1050 Jornal Boehm JJ, Dutton DM, Poust RI.
Shelf life of unrefrigerated succinylcholine chloride injection.
Am J Hosp Pharm 1984 ; 41: 300-302.
1721 Jornal Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1755 Jornal Storms ML, Stewart JT, Warren FW.
Stability of succinylcholine chloride injection at ambient temperature and 4°C in polypropylene syringes.
Int J Pharm Compound 2003 ; 7: 68-70.
2215 Jornal Boehm J.J, Poust R.I.
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Chem Pharm Bull 1984 ; 32, 3: 1113-1119.
2227 Jornal Trusley C, Ben M, Kupiec TC, Trissel LA.
Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Int J Pharm Compound 2008 ; 12, 2: 156-160.
2360 Jornal Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.
Room temperature stability of injectable succinylcholine dichloride.
Int J Pharm Compound 2008 ; 12, 1: 83-85.
3373 Jornal Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58.
3631 Laboratório Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3932 Laboratório Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4274 Jornal Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J.
Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.
J Clin Anesth 2016 ; 35: 551-559.
4528 Jornal Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61

  Mentions Légales